600381 Stock Overview
Qinghai Spring Medicinal Resources Technology Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Qinghai Spring Medicinal Resources Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.61 |
| 52 Week High | CN¥8.28 |
| 52 Week Low | CN¥1.84 |
| Beta | 0.45 |
| 1 Month Change | 19.54% |
| 3 Month Change | 38.85% |
| 1 Year Change | -52.06% |
| 3 Year Change | -57.23% |
| 5 Year Change | -32.02% |
| Change since IPO | -87.43% |
Recent News & Updates
Recent updates
There's Reason For Concern Over Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Massive 30% Price Jump
Nov 11
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump
Jun 24Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues
May 09Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Price Boost Is Out Of Tune With Revenues
Mar 12Shareholder Returns
| 600381 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.8% | -1.9% | -1.2% |
| 1Y | -52.1% | -1.8% | 11.8% |
Return vs Industry: 600381 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 600381 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 600381 volatility | |
|---|---|
| 600381 Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600381 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600381's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 173 | Xuefeng Zhang | www.verygrass.com |
Qinghai Spring Medicinal Resources Technology Co., Ltd. research and development, production, and sale of cordyceps products. It is also involved in the sale of beverages and aquatic products; advertising; and foreign investment business.
Qinghai Spring Medicinal Resources Technology Co., Ltd. Fundamentals Summary
| 600381 fundamental statistics | |
|---|---|
| Market cap | CN¥2.07b |
| Earnings (TTM) | -CN¥287.99m |
| Revenue (TTM) | CN¥251.20m |
8.2x
P/S Ratio-7.2x
P/E RatioIs 600381 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600381 income statement (TTM) | |
|---|---|
| Revenue | CN¥251.20m |
| Cost of Revenue | CN¥147.09m |
| Gross Profit | CN¥104.11m |
| Other Expenses | CN¥392.09m |
| Earnings | -CN¥287.99m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 41.44% |
| Net Profit Margin | -114.64% |
| Debt/Equity Ratio | 0% |
How did 600381 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:08 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Qinghai Spring Medicinal Resources Technology Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Qi He | Huatai Research |